Painful irreversible pulpitis. Diseases of pulp and periapical tissue
Conditions
Interventions
Intervention 1: control group: placebo capsules in the control group, one hour before treatment, orally, containing starch and a small amount of lactose powder. Intervention 2: Intervention group: Nap
Placebo
Treatment - Drugs
control group: placebo capsules in the control group, one hour before treatment, orally, containing starch and a small amount of lactose powder
Intervention group: Naproxen sodium capsule,550mg,Single dose, orally, one hour before to treatment
Sponsors
Jundishapur university of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:the patient included study had not taken any analgesics for at least 12 hours before; have first or second molar of mandible with irreversible pulpitis and normal periapical radiography appearance. Exclusive criteria:patients under 18 years; patients with allergic to naproxen sodium; patients with a history of sensitivity to local anesthetics; pregnant women; a history of significant medical problems; the people who would not have consent to participate in this research project; aspirin;oral anticoagulant medications or plicamycin taken by the patient; history of angioedema; gastrointestinal disease; peptic ulcer; renal or cardiovascular disease; if the tooth has a vital pulp during cavity preparation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: Befor treatment, During treatment. Method of measurement: VAS (visual analog scale). | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side effects from taking the drug. Timepoint: 48 hours after treatment. Method of measurement: Patient chief complaint. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Yazdizadeh
Jundishapur University Of Medical Science
Outcome results
None listed